期刊文献+

中药作用人肺癌A549细胞的实验研究进展 被引量:2

Review on experimental researches in traditional Chinese medicines for human pulmonary adenocarcinoma A549 cells
原文传递
导出
摘要 中医学在防治肿瘤性疾病方面具有独特的疗效,中药的安全性、有效性、低毒性,使之成为现阶段研究抗肿瘤药物的热点。查阅近年来国内外具有代表性的文献,对中药复方、中药单体作用人肺腺癌A549细胞的实验研究结果进行分析归纳,发现很多中药复方及其中药单体被证实对A549细胞产生一定的影响,如诱导A549细胞凋亡和抑制A549细胞增殖,但具体的作用机制尚需深入研究。 Traditional Chinese medicine(TCM) has a unique efficacy in the prevention and treatment of tumor diseases.The safety,efficacy and low toxicity of Chinese medicine,make it become the current research hotspot of antitumor drugs.Traditional Chinese medicine is a rich source of cardiovascular medicine,particular those with antitumor.Refer to the typical literatures at home and abroad in recent years,this article gave some analysis and induction of human lung adenocarcinoma A549 cells treatment with Chinese medicine and Chinese medicine monomer.A lot of traditional Chinese medicine compound and its Chinese medicine monomer was proved to have influence on the A549 cells,such as inducing apoptosis of A549 cells and inhibiting proliferation of A549 cells,but further investigations were required to understand the chemical basis and the exact mechanism.
机构地区 浙江中医药大学
出处 《中华中医药杂志》 CAS CSCD 北大核心 2015年第10期3601-3606,共6页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.81202628)~~
关键词 中药 肺癌 A549细胞 Traditional Chinese medicine Lung cancer A549 cells
  • 相关文献

参考文献45

二级参考文献160

共引文献231

同被引文献31

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部